astrazeneca plc-spons adr (AZN:New York)
Earnings & Estimates Summary - ASTRAZENECA PLC-SPONS ADR (AZN)
2013 revenues at AstraZeneca PLC totaled $25.7B USD, while annual earnings equaled $5.05 per share.
Quarterly Earnings & Estimates - ASTRAZENECA PLC-SPONS ADR (AZN)
AstraZeneca PLC's Quarterly Earnings
AstraZeneca PLC reported 2nd quarter 2014 earnings of $1.30 per share on 08/2/2014.
Annual Earnings & Estimates - ASTRAZENECA PLC-SPONS ADR (AZN)
AstraZeneca PLC's Annual Earnings
AstraZeneca PLC reported annual 2013 earnings of $5.05 per share on 02/8/2014.
Quarterly Revenues - ASTRAZENECA PLC-SPONS ADR (AZN)
AstraZeneca PLC's Quarterly Revenues
AstraZeneca PLC had 2nd quarter 2014 revenues of $6.5B USD. This bettered the $6.3B USD consensus of the 18 analysts covering the company. This was 3.6% above the prior year's 2nd quarter results.
Annual Revenues - ASTRAZENECA PLC-SPONS ADR (AZN)
AstraZeneca PLC's Annual Revenues
AstraZeneca PLC had revenues for the full year 2013 of $25.7B USD. This was -8.1% below the prior year's results.
|AbbVie Inc||$60.35 USD||-2.77|
|Biogen Idec Inc||$389.16 USD||+35.91|
|Celgene Corp||$119.16 USD||-1.71|
|Eli Lilly & Co||$72.00 USD||-0.11|
|Novo Nordisk A/S||kr295.50 DKK||-4.40|
|View Industry Companies|